Mast cell control of endogenous, antigen-specific CD4 T cell immunity
Mast cell control of endogenous, antigen-specific CD4 T cell immunity
批准号:
9019796
负责人:
James B McLachlan
金额:
$22.58万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-01-19 至 2017-12-31
关键词:
AddressAffectAntibodiesAntibody FormationAntigen PresentationAntigensAsthmaAutomobile DrivingB-LymphocytesBacteriaBone MarrowCD4 Positive T LymphocytesCell CountCell physiologyCellsCessation of lifeComplexConflict (Psychology)DataDevelopmentDiseaseEarElementsEquilibriumEvolutionGoalsHealthHelper-Inducer T-LymphocyteHistocompatibility Antigens Class IIHumanHypersensitivityImmuneImmune responseImmune systemImmunityImmunizationInfectionInjection of therapeutic agentInterferonsInterleukin-4InvestigationKnock-outKnowledgeLaboratoriesLeadLigationLiteratureLymphoidMHC Class II GenesMaintenanceMediatingMediator of activation proteinMissionModelingMusOrganismOutcomeParasitesPhenotypePhysiologicalPlayPopulationProductionReportingResearchResearch DesignRoleSignal TransductionSkinSkin TissueStimulusSurfaceT cell differentiationT cell responseT-Cell ActivationT-LymphocyteTestingTh1 CellsTh2 CellsTherapeutic InterventionTimeTissuesVaccinesWorkadaptive immunityantimicrobialarmbasechemokinecombatcytokinehuman diseasekillingslymph nodesmacrophagemast cellmigrationmucosal sitenovelpathogenpublic health relevancereconstitutionresearch studyresponseuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Mast cells have long been known to be important cellular causes of asthma and allergy. Recent studies have challenged that pathophysiological paradigm in favor of a much more diverse role for mast cells in various aspects of immunity. Conflicting reports in the literature have assigned both effector and suppressor roles to mast cells based on how they are stimulated. While it is clear that mast cells are potent innate immune cells essential for early clearance of pathogens, such as bacteria and parasites, far less is known about what role mast cells play in adaptive immunity, especially with respect to their effect on helper T cell immunity. Our preliminary experiments using major histocompatibility complex class II (MHCII) tetramers to examine mast cell effects on endogenous, antigen-specific helper CD4 T cell immunity showed that inducing mast cell degranulation in the tissue led to a significant increase in antigen-specific helper CD4 T cell numbers in draining lymph nodes. Further, we established that a lack of mast cells led to a marked decrease in antigen-specific CD4 T cell accumulation in antigen-containing tissue. These combined results, in addition to our past work, lead us to the hypothesis that mast cells contribute to endogenous helper T cell population expansion and migration and, ultimately, regulate helper T cell functional phenotypes. We further posit that this T cell activation is mediated through direct mast
cell effects on CD4 T cells, including cytokine production by mast cells and that this is determined by how mast cells are initially activated. We will test this hypothesis using MHCII tetramers to analyze endogenous, antigen-specific CD4 T cells combined with mast cell deficient mice or mast cell deficient mice reconstituted with bone marrow derived mast cells. Aim 1 will examine the role for mast cells in initiating and maintaining the antigen-specific CD4 T
cell response in antigen-containing tissue and antigen-draining lymph nodes while Aim 2 will assess the function of mast cells in driving CD4 T cell Th phenotypes in response to different mast cell activation stimuli. These studies are designed to examine multiple mast cell effects on antigen-specific CD4 helper T cell immunity. This investigation should provide novel opportunities to guide the response in favor of pathogen elimination leading to better mast cell based therapeutic interventions benefitting human health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using combination adjuvants to direct and control immune responses at the intestinal mucosa
-
批准号:9108588
-
项目类别:
-
资助金额:$39.33万
-
财政年份:2016
-
负责人:James B McLachlan
-
依托单位:
Using combination adjuvants to direct and control immune responses at the intestinal mucosa
-
批准号:9247816
-
项目类别:
-
资助金额:$54.66万
-
财政年份:2016
-
负责人:James B McLachlan
-
依托单位:
Using combination adjuvants to direct and control immune responses at the intestinal mucosa
-
批准号:9897616
-
项目类别:
-
资助金额:$38.07万
-
财政年份:2016
-
负责人:James B McLachlan
-
依托单位:
Organ-specific CD4 T cell responses regulate Salmonella persistence
-
批准号:8868025
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2013
-
负责人:James B McLachlan
-
依托单位:
Organ-specific CD4 T cell responses regulate Salmonella persistence
-
批准号:8703005
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2013
-
负责人:James B McLachlan
-
依托单位:
Organ-specific CD4 T cell responses regulate Salmonella persistence
-
批准号:9085228
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2013
-
负责人:James B McLachlan
-
依托单位:
Organ-specific CD4 T cell responses regulate Salmonella persistence
-
批准号:8578801
-
项目类别:
-
资助金额:$35.37万
-
财政年份:2013
-
负责人:James B McLachlan
-
依托单位:
Antigen presentation to T cells in nonlymphoid tissue
-
批准号:7054953
-
项目类别:
-
资助金额:$4.88万
-
财政年份:2006
-
负责人:James B McLachlan
-
依托单位:
Antigen presentation to T cells in nonlymphoid tissue
-
批准号:7213343
-
项目类别:
-
资助金额:$3.23万
-
财政年份:2006
-
负责人:James B McLachlan
-
依托单位:
海外基金